GlobeNewswire Inc.··NaOncolytics Biotech Presents Pelareorep Data Showing Immune Response Across GI Tumors
Oncolytics Biotech presents pelareorep data showing immune activation across gastrointestinal tumors, with FDA alignment on anal cancer pivotal study.
ONCYcolorectal cancerbreast cancer